DoubleChecks

What was claimed

New study reports Fenbendazole linked to remission or near-remission in THREE Stage IV Cancer Patients (breast, prostate, melanoma) with dramatic tumor regression and long-lasting remission without chemotherapy. Clinical trials should be urgently initiated.

Our verdict

Needs caution

The case series reported sustained outcomes and no chemotherapy, but patients received other treatments such as hormone therapy, radiation, surgery, supplements, or androgen-deprivation therapy. These uncontrolled cases cannot show that fenbendazole caused tumor regression or remission. This is a recommendation rather than a directly testable fact. Fenbendazole may warrant properly designed research, but available sources do not establish an urgent clinical need or demonstrated effectiveness in humans; experts report insufficient evidence of safety and efficacy. (Only 1 of 3 AI systems responded.)

1 AI system responded15 sources citedChecked Sep 25, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

The patients had dramatic tumor regression and long-lasting remission without chemotherapy.

Misleading93%
1 AI checked

Clinical trials should be urgently initiated.

Can’t verify72%
1 AI checked

A study reported three stage IV cancer patients with breast, prostate, and melanoma cancers who achieved remission or near-remission while taking fenbendazole.

Verified96%
1 AI checked

Verified against 15 sources

pmc.ncbi.nlm.nih.govcancer.orgpublichealthpolicyjournal.comonedaymd.comsanarelab.sciencethefenbendazole.comar.iiarjournals.orgmsn.comfenbendazole.substack.comcancerexplained.orgonedaymd.comsanarelab.sciencepolitifact.comcancerexplained.orgkarger.com

Detailed Analysis

The case series did report three stage IV patients with breast, prostate, and melanoma cancers who experienced complete or near-complete remission while using fenbendazole with other treatments.[1] However, the paper was later listed as retracted, and the cases cannot establish that fenbendazole caused the outcomes.[15] Reliable medical sources state that human evidence is insufficient and no clinical trials have proven fenbendazole effective against cancer.[2] [10]

Why this verdict

The case series did report three stage IV patients with breast, prostate, and melanoma cancers who experienced complete or near-complete remission while using fenbendazole with other treatments.[1] However, the paper was later listed as retracted, and the cases cannot establish that fenbendazole caused the outcomes.[15] Reliable medical sources state that human evidence is insufficient and no clinical trials have proven fenbendazole effective against cancer.[2] [10]

Claims checked

The patients had dramatic tumor regression and long-lasting remission without chemotherapy.

Misleading93%
The case series reported sustained outcomes and no chemotherapy, but patients received other treatments such as hormone therapy, radiation, surgery, supplements, or androgen-deprivation therapy.[1] These uncontrolled cases cannot show that fenbendazole caused tumor regression or remission.

This claim may mislead readers without added context.

Clinical trials should be urgently initiated.

Can’t verify72%
This is a recommendation rather than a directly testable fact. Fenbendazole may warrant properly designed research, but available sources do not establish an urgent clinical need or demonstrated effectiveness in humans; experts report insufficient evidence of safety and efficacy.[2] [10]

A study reported three stage IV cancer patients with breast, prostate, and melanoma cancers who achieved remission or near-remission while taking fenbendazole.

Verified96%
A 2025 case series described three such patients and reported two complete remissions and one near-complete remission.[1] The report was subsequently identified as retracted, which substantially limits its evidentiary value.[15]

What other AI think

ClaudeDid not respond
ChatGPTDid not respond

Share this result

Try DoubleChecks